AuroBlog - Aurous Healthcare Clinical Trials blog
AUGUST 4, 2024
Diagnoses for sexually transmitted infections, or STIs, are increasing in older adults. The Centers for Disease Control and Prevention reports the number of people older than 65 diagnosed with chlamydia, gonorrhea or syphilis in the U.S. increased about three-, five- and sevenfold, respectively, from 2010 to 2023.
BioSpace
AUGUST 4, 2024
Longeveron and Lexeo Therapeutics are working on CGT therapies to treat Alzheimer’s disease, but it’s not clear whether they have a better chance of success than traditional approaches.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuroBlog - Aurous Healthcare Clinical Trials blog
AUGUST 4, 2024
The Union health ministry has initiated the process to fill in the top most post in the Central Drugs Standard Control Organisation (CDSCO), with the tenure of the current Drugs Controller General of India (DCGI) expected to come to an end by February next year.
JAMA Internal Medicine
AUGUST 4, 2024
Prescribing rates of glucagon-like peptide 1 (GLP-1) and gastric inhibitory polypeptide (GIP) receptor agonists are increasing rapidly, given their recently demonstrated efficacy in causing weight loss. Additional benefits include reduction in cardiovascular risk in patients with obesity, diabetes, and chronic kidney disease; decreased heart failure–related symptoms in patients with a preserved ejection fraction; and improved glycemic control.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
AUGUST 4, 2024
An FDA advisory committee has recommended approval of Zevra Therapeutics' arimoclomol for the ultra-rare disorder Niemann-Pick disease, three years after the regulator rejected the drug.The Genetic Metabolic Diseases Advisory Committee (GeMDAC) voted 11 to five that the data support the approval of the drug for Niemann-Pick disease type C (NPC), a progressive genetic disorder that leads to the accumulation of fatty substances in tissues and can cause a range of symptoms, including liver and lung
JAMA Internal Medicine
AUGUST 4, 2024
This Teachable Moment describes a 62-year-old man with thyrotoxicosis due to excess levothyroxine exposure during tirzepatide treatment that induced rapid weight loss.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Drug Patent Watch
AUGUST 4, 2024
This chart shows the drugs with the most patents in Colombia.
Drug Patent Watch
AUGUST 4, 2024
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim a
Drug Patent Watch
AUGUST 4, 2024
Annual Drug Patent Expirations for ACUVAIL Acuvail is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier.
Drug Patent Watch
AUGUST 4, 2024
Handling drug patent opposition proceedings is a crucial step in ensuring the quality and validity of granted patents in the pharmaceutical industry.
Expert insights. Personalized for you.
246 
Let's personalize your content